Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Shortage reports
Actual shortage:
61 (5%)
Anticipated shortage:
0 (0%)
Avoided shortage:
36 (3%)
Resolved:
1223 (93%)
1320
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
283 (99%)
Reversed:
2 (1%)
287
211 (13%)
35 (56%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-ROSUVASTATIN | 5MG | TABLET | Resolved | 2017-08-11 | 2018-01-26 | 18893 |
| PMS-ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-04-20 | 2017-10-11 | 7494 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2017-04-20 | 2018-02-20 | 7497 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2017-04-20 | 2018-04-19 | 7500 |
| PMS-ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-10-27 | 2018-05-18 | 27359 |
| PMS-ROSUVASTATIN | 40MG | TABLET | Resolved | 2018-05-04 | 2018-06-07 | 48563 |
| PMS-ROSUVASTATIN | 20MG | TABLET | Resolved | 2018-05-18 | 2018-06-29 | 49753 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Resolved | 2018-02-12 | 2018-06-07 | 39555 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Resolved | 2025-02-05 | 2025-03-17 | 249585 |
| PMS-SALBUTAMOL | 0.5MG | SOLUTION | Actual shortage | 2025-05-12 | 2025-05-12 | 257033 |
| PMS-SALBUTAMOL | 1MG | SOLUTION | Resolved | 2024-11-27 | 2025-03-17 | 243924 |
| PMS-SALBUTAMOL | 1MG | SOLUTION | Actual shortage | 2025-04-25 | 2025-04-25 | 255743 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Actual shortage | 2025-04-01 | 2025-04-01 | 253879 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Resolved | 2024-07-30 | 2024-09-09 | 234078 |
| PMS-SALBUTAMOL | 1MG | SOLUTION | Resolved | 2024-07-30 | 2024-09-30 | 234075 |
| PMS-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2025-01-29 | 2025-04-01 | 249029 |
| PMS-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2022-11-11 | 2023-04-06 | 174381 |
| PMS-SALBUTAMOL | 2MG | SOLUTION | Resolved | 2024-04-05 | 2024-05-10 | 224605 |
| PMS-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2017-04-07 | 2017-07-25 | 6152 |
| PMS-SERTRALINE | 100MG | CAPSULE | Resolved | 2019-07-31 | 2020-06-10 | 90485 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| ACET CODEINE 30 | 300MG 30MG | TABLET | Discontinued | 2018-02-22 | 2018-07-23 | 40586 |
| ACET CODEINE 60 | 300MG 60MG | TABLET | Discontinued | 2019-01-16 | 2019-01-17 | 72608 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137986 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137995 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137998 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
| EGOZINC-HC | 0.5% 0.5% | OINTMENT | Discontinued | 2020-06-15 | 2021-10-27 | 117754 |